Cargando…
初始易瑞沙治疗有效的晚期肺腺癌二次使用易瑞沙的疗效分析
BACKGROUND AND OBJECTIVE: Gefitinib is an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) that has been widely used for the treatment of non-small cell lung cancer (NSCLC). It is most effective in women, as well as in patients who have never smoked, have pulmonary adenocarcinom...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999970/ https://www.ncbi.nlm.nih.gov/pubmed/22237124 http://dx.doi.org/10.3779/j.issn.1009-3419.2012.01.09 |